Literature DB >> 8240393

Protein phosphatase 2A and its [3H]cantharidin/[3H]endothall thioanhydride binding site. Inhibitor specificity of cantharidin and ATP analogues.

Y M Li1, C Mackintosh, J E Casida.   

Abstract

The target site for cantharidin (CA) and its analogues was isolated recently from mouse liver and identified as protein phosphatase (PP2A) in the heterodimeric form known as PP2A2. The most toxic CA analogue, endothall thioanhydride (ETA) (mouse i.p. LD50 0.3 mg/kg), appears to have the same binding site in mouse liver and brain based on studies comparing [3H]ETA and [3H]CA. ATP and its nonhydrolyzable analogues and pyrophosphate and related compounds including phosphonoformic acid inhibited both [3H]CA and [3H]ETA binding with IC50 values ranging from 2 to 81 microM. As with CA itself, the most potent inhibitors have two negatively charged groups in close proximity to each other. Inhibition of [3H]CA binding by 5,5'-dithiobis(2-nitrobenzoic acid) and stimulation by N-ethylmaleimide indicated the involvement of a thiol site in the CA-binding domain. CA and three analogues (cantharidic acid, palasonin and endothall) inhibited PP2A and protein phosphatase 1 (PP1) but not PP2B or PP2C. The catalytic subunit of PP2A was 5- to 12-fold more sensitive to these CA analogues than the catalytic subunit of PP1. CA and the herbicide endothall also inhibited spinach leaf PP1 and PP2A and, at 50 microM, decreased the PP2A-mediated light-induced activation of nitrate reductase in intact spinach leaves by 62 and 56%, respectively. This is consistent with PP2A as their site of action in plants, and indicates the potential use of CA analogues as pharmacological probes to investigate cellular processes that are regulated by reversible protein phosphorylation in vivo.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8240393     DOI: 10.1016/0006-2952(93)90109-a

Source DB:  PubMed          Journal:  Biochem Pharmacol        ISSN: 0006-2952            Impact factor:   5.858


  30 in total

1.  Protein phosphatase 1, protein phosphatase 2A, and calcineurin play a role in estrogen-mediated neuroprotection.

Authors:  Kun Don Yi; James W Simpkins
Journal:  Endocrinology       Date:  2008-06-19       Impact factor: 4.736

2.  Hamster pancreatic beta cell lines with altered sensitivity towards apoptotic signalling by phosphatase inhibitors.

Authors:  A Krautheim; P Brechlin; K Becker; M Winkler; H J Steinfelder
Journal:  Br J Pharmacol       Date:  2000-02       Impact factor: 8.739

3.  Dephosphorylation and inactivation of NPR2 guanylyl cyclase in granulosa cells contributes to the LH-induced decrease in cGMP that causes resumption of meiosis in rat oocytes.

Authors:  Jeremy R Egbert; Leia C Shuhaibar; Aaron B Edmund; Dusty A Van Helden; Jerid W Robinson; Tracy F Uliasz; Valentina Baena; Andreas Geerts; Frank Wunder; Lincoln R Potter; Laurinda A Jaffe
Journal:  Development       Date:  2014-09       Impact factor: 6.868

4.  Structural characterization of the membrane-associated regulatory subunit of type I cAMP-dependent protein kinase by mass spectrometry: identification of Ser81 as the in vivo phosphorylation site of RIalpha.

Authors:  K M Boeshans; K A Resing; J B Hunt; N G Ahn; J B Shabb
Journal:  Protein Sci       Date:  1999-07       Impact factor: 6.725

5.  Inhibition of specific binding of okadaic acid to protein phosphatase 2A by microcystin-LR, calyculin-A and tautomycin: method of analysis of interactions of tight-binding ligands with target protein.

Authors:  A Takai; K Sasaki; H Nagai; G Mieskes; M Isobe; K Isono; T Yasumoto
Journal:  Biochem J       Date:  1995-03-15       Impact factor: 3.857

6.  Stimulation of protein phosphatases as a mechanism of the muscarinic-receptor-mediated inhibition of cardiac L-type Ca2+ channels.

Authors:  S Herzig; A Meier; M Pfeiffer; J Neumann
Journal:  Pflugers Arch       Date:  1995-02       Impact factor: 3.657

7.  Combination of reverse and chemical genetic screens reveals angiogenesis inhibitors and targets.

Authors:  Mattias Kalén; Elisabet Wallgard; Noomi Asker; Aidas Nasevicius; Elisabet Athley; Erik Billgren; Jon D Larson; Shannon A Wadman; Elizabeth Norseng; Karl J Clark; Liqun He; Linda Karlsson-Lindahl; Ann-Katrin Häger; Holger Weber; Hellmut Augustin; Tore Samuelsson; Chelsy K Kemmet; Carly M Utesch; Jeffrey J Essner; Perry B Hackett; Mats Hellström
Journal:  Chem Biol       Date:  2009-04-24

8.  Identification of novel host-targeted compounds that protect from anthrax lethal toxin-induced cell death.

Authors:  Louise H Slater; Erik C Hett; Kevin Mark; Nicole M Chumbler; Deepa Patel; D Borden Lacy; R John Collier; Deborah T Hung
Journal:  ACS Chem Biol       Date:  2013-02-04       Impact factor: 5.100

9.  Inhibition of protein phosphatase 1 stimulates secretion of Alzheimer amyloid precursor protein.

Authors:  E F da Cruz e Silva; O A da Cruz e Silva; C T Zaia; P Greengard
Journal:  Mol Med       Date:  1995-07       Impact factor: 6.354

10.  Identification of an additional supraspinal component to the analgesic mechanism of action of buprenorphine.

Authors:  Zhe Ding; Robert B Raffa
Journal:  Br J Pharmacol       Date:  2009-04-30       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.